Repligen Corp. (RGEN)
123.03
-1.94
(-1.55%)
USD |
NASDAQ |
Mar 03, 16:00
123.03
0.00 (0.00%)
After-Hours: 18:57
Repligen Price : 123.03 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Orthofix Medical, Inc. | 13.02 |
| InfuSystem Holdings, Inc. | 9.21 |
| Abbott Laboratories | 113.58 |
| Accuray, Inc. | 0.5281 |
| Plus Therapeutics, Inc. | 0.2917 |
Price Related Metrics
| PE Ratio | 142.31 |
| PS Ratio | 9.426 |
| Price to Book Value | 3.290 |
| Price to Free Cash Flow | 75.90 |
| Earnings Yield | 0.70% |
| Market Cap | 6.930B |
| Operating PE Ratio | 136.71 |
| Normalized PE Ratio | 150.77 |